BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28814287)

  • 1. Early onset coats' disease initially treated as unilateral ROP at 39 weeks postmenstrual age: a case report.
    Peng J; Zhang Q; Chen C; Huang Q; Li Y; Zhao P
    BMC Ophthalmol; 2017 Aug; 17(1):145. PubMed ID: 28814287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment for Coats' disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases.
    Kodama A; Sugioka K; Kusaka S; Matsumoto C; Shimomura Y
    BMC Ophthalmol; 2014 Mar; 14():36. PubMed ID: 24666524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
    Ramasubramanian A; Shields CL
    Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranibizumab injection and laser photocoagulation to treat type 1 retinopathy of prematurity after 40 weeks post menstrual age: a retrospective case series study.
    Lyu J; Zhang Q; Chen C; Xu Y; Ji X; Zhao P
    BMC Ophthalmol; 2019 Feb; 19(1):60. PubMed ID: 30808338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats' disease.
    Zhang L; Ke Y; Wang W; Shi X; Hei K; Li X
    Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1339-1346. PubMed ID: 29549425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful use of intravitreal ranibizumab injection and combined treatment in the management of Coats' disease.
    Yang Q; Wei W; Shi X; Yang L
    Acta Ophthalmol; 2016 Jun; 94(4):401-6. PubMed ID: 27150442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant anti-VEGF therapy in Coats' disease].
    Fiorentzis M; Stavridis E; Seitz B; Viestenz A
    Ophthalmologe; 2015 May; 112(5):451-4. PubMed ID: 25134462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease.
    Kumar K; Raj P; Chandnani N; Agarwal A
    Int Ophthalmol; 2019 Feb; 39(2):465-470. PubMed ID: 29380183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.
    Li S; Deng G; Liu J; Ma Y; Lu H
    BMC Ophthalmol; 2017 May; 17(1):76. PubMed ID: 28532448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the diagnosis and treatment of Coats' disease.
    Yang X; Wang C; Su G
    Int Ophthalmol; 2019 Apr; 39(4):957-970. PubMed ID: 30895419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children.
    Kabataş EU; Kurtul BE; Altıaylık Özer P; Kabataş N
    Curr Eye Res; 2017 Jul; 42(7):1054-1058. PubMed ID: 28128986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescein Angiographic Abnormalities in the Contralateral Eye with Normal Fundus in Children with Unilateral Coats' Disease.
    Jung EH; Kim JH; Kim SJ; Yu YS
    Korean J Ophthalmol; 2018 Feb; 32(1):65-69. PubMed ID: 29376220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoschisis in the setting of Coats' disease.
    Yannuzzi NA; Tzu JH; Hess DJ; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):172-4. PubMed ID: 24635161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' disease.
    Raoof N; Quhill F
    Middle East Afr J Ophthalmol; 2013; 20(3):256-8. PubMed ID: 24014992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative fluorescein angiography-guided treatment in children with early Coats' disease.
    Suzani M; Moore AT
    Ophthalmology; 2015 Jun; 122(6):1195-202. PubMed ID: 25824326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INTRAVITREAL RANIBIZUMAB INJECTION AND RETINAL LASER PHOTOCOAGULATION TREATMENT FOR ADULT-ONSET COATS DISEASE.
    Plaza-Laguardia C; Pascual-Camps I; Bayón-Porras MR; Sánchez-Cañizal J; Gallego-Pinazo R
    Retin Cases Brief Rep; 2021 Sep; 15(5):532-535. PubMed ID: 31913217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coats' disease of adult-onset in 48 eyes.
    Rishi E; Rishi P; Appukuttan B; Uparkar M; Sharma T; Gopal L
    Indian J Ophthalmol; 2016 Jul; 64(7):518-23. PubMed ID: 27609165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhegmatogenous retinal detachment in Coats' disease: a case report.
    Khadka S; Byanju R; Parajuli S
    J Med Case Rep; 2021 Dec; 15(1):631. PubMed ID: 34969406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coats' disease diagnosed in adulthood.
    Smithen LM; Brown GC; Brucker AJ; Yannuzzi LA; Klais CM; Spaide RF
    Ophthalmology; 2005 Jun; 112(6):1072-8. PubMed ID: 15882905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual outcomes after treatment in pediatric patients with Coats' disease.
    Chiu HH; Wan MJ; Kertes PJ; Muni RH; Lam WC
    Can J Ophthalmol; 2019 Dec; 54(6):647-652. PubMed ID: 31836093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.